Skip to main content

What the FDA labels say about taking them together

Nelfinavir and sirolimus

Nelfinavir's FDA label of December 11, 2025 names sirolimus in its drug interactions section; the sirolimus labels PlainMeds reads (4) do not name nelfinavir. The nelfinavir label: “Concentrations of these immunosuppressants and nelfinavir may be increased by coadministration of these agents with nelfinavir.”

Check it at the source: the nelfinavir FDA label on DailyMed (effective December 11, 2025, AGOURON); the sirolimus FDA label on DailyMed (effective January 28, 2026, Glenmark Pharmaceuticals Inc., USA).

What does the nelfinavir label say about sirolimus?

Nelfinavir label, drug interactions

Concomitant Drug Class/Drug Name: Cyclosporine Tacrolimus Sirolimus; Effect on Concentration: ↑ immuno-suppressants ↑ nelfinavir; Clinical Comment: Concentrations of these immunosuppressants and nelfinavir may be increased by coadministration of these agents with nelfinavir.

Source: FDA drug label (VIRACEPT), AGOURON, effective December 11, 2025 (SPL set e72c2bc6-9462-4a2e-8e1d-b97592376cbd), via openFDA; the full label on DailyMed

What does the sirolimus label say about nelfinavir?

Sirolimus's label (effective January 28, 2026) and its 3 other brand-application labels do not name nelfinavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (sirolimus), Glenmark Pharmaceuticals Inc., USA, effective January 28, 2026 (SPL set 57fb4d90-3ccb-4a69-af1e-53be83f7a504), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Nelfinavir generic labelers
17Sirolimus generic labelers
NelfinavirSirolimus
Labeled forHIVOrgan transplant rejection
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.723 per tablet 1 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?